Company intelligence / Profile preview

Ivy Laboratories

West Lafayette, Indiana, United Statesivybraintumorcenter.org ↗

Ownership: Private
Development stage: Commercial

Overview

The company has developed the IvyGene blood test platform that uses advanced sequencing to analyze cell-free DNA methylation patterns in whole blood. The technology can confirm the presence of certain cancers as early as stage 1. The liver-specific test is commercially available; breast and colon-specific tests are under development.

Therapeutic areas: Oncology
Modalities: Diagnostic testDNA methylation analysis
Industry: Molecular Diagnostics

Partnerships

Collaborations with leading scientists, physicians, research institutions globally; specific partners not named

Beyond the preview

Go deeper on Ivy Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ivy Laboratories.

Explore the full profile